S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This healthcare stock making a buzz with 160% growth
How major US stock indexes fared Monday, 2/26/2024
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze

Krystal Biotech (KRYS) Short Interest Ratio & Short Volume

$157.00
+45.67 (+41.02%)
(As of 02/26/2024 ET)

Krystal Biotech Short Interest Data

Current Short Volume
2,030,000 shares
Previous Short Volume
1,970,000 shares
Change Vs. Previous Month
+3.05%
Dollar Volume Sold Short
$225.84 million
Short Interest Ratio / Days to Cover
6.6
Last Record Date
January 31, 2024
Outstanding Shares
28,210,000 shares
Percentage of Shares Shorted
7.20%
Today's Trading Volume
2,236,955 shares
Average Trading Volume
317,541 shares
Today's Volume Vs. Average
704%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Krystal Biotech ?

Sign up to receive the latest short interest report for Krystal Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KRYS Short Interest Over Time

KRYS Days to Cover Over Time

KRYS Percentage of Float Shorted Over Time


Krystal Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20242,030,000 shares $225.84 million +3.1%N/A6.6 $111.25
1/15/20241,970,000 shares $252.87 million -9.2%N/A6.3 $128.36
12/31/20232,170,000 shares $269.21 million +11.3%N/A7.1 $124.06
12/15/20231,950,000 shares $225.73 million -8.0%N/A6.4 $115.76
11/30/20232,120,000 shares $220.97 million +2.4%N/A6.8 $104.23
11/15/20232,070,000 shares $206.09 million -1.4%N/A6.8 $99.56
10/31/20232,100,000 shares $245.43 million +7.1%N/A7.1 $116.87
10/15/20231,960,000 shares $223.01 million -0.5%N/A7.4 $113.78
9/30/20231,970,000 shares $228.52 million +23.9%N/A7.4 $116.00
9/15/20231,590,000 shares $191.07 million +6.0%N/A5.9 $120.17
8/31/20231,500,000 shares $186.72 million -2.6%N/A5.7 $124.48
8/15/20231,540,000 shares $187.82 million +15.8%N/A5.3 $121.96
7/31/20231,330,000 shares $171.70 million -7.6%N/A4.1 $129.10
7/15/20231,440,000 shares $181.83 million +6.7%6.8%4.7 $126.27
6/30/20231,350,000 shares $158.49 million +3.1%6.4%4.5 $117.40
6/15/20231,310,000 shares $163.37 million +10.1%6.2%4.3 $124.71
5/31/20231,190,000 shares $140.24 million +3.5%5.6%4.3 $117.85
5/15/20231,150,000 shares $103.56 million -0.9%5.5%4.4 $90.05
4/30/20231,160,000 shares $97.44 million -7.2%5.5%5.7 $84.00
4/15/20231,250,000 shares $107.98 million +4.2%6.0%6.4 $86.38
3/31/20231,200,000 shares $96.07 million +5.3%5.8%5.9 $80.06
3/15/20231,140,000 shares $83.80 million -4.2%5.5%5.9 $73.51
2/28/20231,190,000 shares $97.47 million +6.3%5.7%6.3 $81.91
2/15/20231,120,000 shares $82.33 million +6.7%5.4%6.5 $73.51
1/31/20231,050,000 shares $87.28 million -7.1%5.1%6.1 $83.12
1/15/20231,130,000 shares $93.73 million +14.4%5.4%6.5 $82.95
12/30/2022988,100 shares $78.28 million -10.2%4.8%5.9 $79.22
12/15/20221,100,000 shares $86.24 million -9.1%5.3%6.9 $78.40
11/30/20221,210,000 shares $94.07 million -3.2%5.9%7.8 $77.74
11/15/20221,250,000 shares $96.51 million -4.6%6.1%7.7 $77.21
10/31/20221,310,000 shares $100.22 million +3.2%6.4%7.9 $76.50
10/15/20221,270,000 shares $83.83 million -3.1%6.2%7.6 $66.01
9/30/20221,310,000 shares $91.31 million +7.4%6.4%7.9 $69.70
9/15/20221,220,000 shares $86.97 million -4.7%6.3%7.3 $71.29
8/31/20221,280,000 shares $89.74 million -5.9%6.6%7.2 $70.11
8/15/20221,360,000 shares $105.48 million -0.7%7.0%7.9 $77.56
7/31/20221,370,000 shares $99.43 million -1.4%7.0%7.5 $72.58
7/15/20221,390,000 shares $100.66 million -10.9%7.1%7.7 $72.42
6/30/20221,560,000 shares $102.43 million -2.5%7.9%8.6 $65.66
6/15/20221,600,000 shares $85.34 million +0.6%8.1%8.4 $53.34













KRYS Short Interest - Frequently Asked Questions

What is Krystal Biotech's current short interest?

Short interest is the volume of Krystal Biotech shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 2,030,000 shares of KRYS short. Learn More on Krystal Biotech's current short interest.

What is a good short interest ratio for Krystal Biotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRYS shares currently have a short interest ratio of 7.0. Learn More on Krystal Biotech's short interest ratio.

Which institutional investors are shorting Krystal Biotech?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Krystal Biotech: Wolverine Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, Cutler Group LLC CA, and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Krystal Biotech's short interest increasing or decreasing?

Krystal Biotech saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 2,030,000 shares, an increase of 3.0% from the previous total of 1,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Krystal Biotech's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Krystal Biotech: Fortrea Holdings Inc. (6.72%), Arcellx, Inc. (11.94%), MoonLake Immunotherapeutics (14.51%), Summit Therapeutics Inc. (1.61%), Merus (8.04%), Inhibrx, Inc. (6.74%), Adaptimmune Therapeutics plc (0.47%), Arcus Biosciences, Inc. (22.34%), BioCryst Pharmaceuticals, Inc. (14.18%), Alector, Inc. (8.34%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Krystal Biotech stock?

Short selling KRYS is an investing strategy that aims to generate trading profit from Krystal Biotech as its price is falling. KRYS shares are trading up $45.67 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Krystal Biotech?

A short squeeze for Krystal Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRYS, which in turn drives the price of the stock up even further.

How often is Krystal Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRYS, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:KRYS) was last updated on 2/27/2024 by MarketBeat.com Staff